Objectives
To describe contemporary radical prostatectomy (RP) practice using the British Association of Urological Surgeons (BAUS) data and audit project and to observe differences in practice in relation to surgeon or centre case-volume.
Patients and Methods
Data on 13 920 RP procedures performed by 179 surgeons across 86 centres were recorded on the BAUS data and audit platform between 1 January 2014 and 31 December 2015. This equates to~95% of total RPs performed over this period when compared to Hospital Episode Statistics (HES) data. Centre case-volumes were categorised as 'high' (>200), 'medium' (100-200) and 'low' (<100); surgeon case-volumes were categorised as 'high' (>100) and 'low' (<100). Differences in surgical practice and selected outcome measures were observed between groups. All data and volume categories were for the combined 2-year period.
Results
The median number of RPs performed over the 2-year period was 63.5 per surgeon and 164 per centre. Overall, surgical approach was robot-assisted laparoscopic RP (RALP) in 65%, laparoscopic RP (LRP) in 23%, and open RP (ORP) in 12%. The dominant approach in high-case-volume centres and by high-case-volume surgeons was RALP (74.3% and 69.2%, respectively). There was a greater percentage of ORPs reported by low-volume surgeons and centres when compared to higher volume equivalents. In all, 51.6% of all patients in this series underwent RP in high-case-volume centres using robot-assisted surgery (RAS). High-case-volume surgeons performed nerve-sparing (NS) procedures on 57.3% of their cases; low-volume surgeons performing NS on 48.2%. Overall, lymph node dissection (LND) rates were very similar across the groups. An 'extended' LND was more commonly performed in high-volume centres (22.1%). The median length of stay (LOS) was lowest in patients undergoing RALP at high-volume centres (1 day) and highest in ORP across all volume categories (3-4 days). Reported pT2 positive surgical margin (PSM) rate varied by technique, centre volume, and surgeon volume. In general, observed PSM rates were lower when RALP was the surgical approach (14.4%) and when high-volume surgeons were compared to low-volume surgeons (13.6% vs 17.7%). Transfusion rates were highest in ORP across all centres and surgeons (2.96-4.49%) compared to techniques using a minimally-invasive approach (0.25-2.41%). Training cases ranged from 0.5% in low-volume centres to 6.0% in high-volume centres.
Conclusions
Compliance with data registration for centres and surgeons performing RP is high in the present series. Most RPs were performed in high-case-volume centres and by highcase-volume surgeons, with the most common approaches being minimally invasive and specifically RAS. High-casevolume centres and surgeons reported higher rates of extended LND and training cases. Higher-case-volume surgeons reported lower pT2 PSM rates, whilst the most marked differences in transfusion rates and LOS were seen when ORP was compared to minimally invasive approaches. Caution must be applied when interpreting these differences on the basis of this being registry datacausality cannot be assumed.
Introduction
Data on radical prostatectomy (RP) practice were made public for the first time in 2014 as part of the Consultants Outcomes Publication (COP), an NHS England initiative managed by the Healthcare Quality Improvement Programme (HQIP) [1] . Information is submitted on to the BAUS electronic data registry, collated, validated, and specific elements are then published. In England, and more recently Scotland, it has been deemed 'mandatory' for surgeons to upload their RP data. Although this is not currently enforced, compliance rates for basic demographics and surgeries performed is high. Data from surgeons practicing in Wales, Northern Ireland and the Irish Republic can be voluntarily uploaded. Data on individual surgeons are made publicly available through NHS and BAUS websites [2, 3] , detailing the number of procedures performed, surgical approach, length of stay (LOS), and high-grade complication rates.
Guidance from the National Institute for Health and Care Excellence (NICE) recommend that RP is offered to men with localised intermediate-risk disease and to those with localised high-risk disease with a prospect of long-term disease control [4] . As part of this, the adoption of robotassisted laparoscopic radical prostatectomy (RALP) was recommended by NICE in 2014 [4] . The Improving Outcomes Guidance (IOG) has previously recommended centralisation of major urological pelvic cancer surgeries to teams performing ≥50 cases/year [5] . NICE has further recommended that, in order for robot-assisted surgery (RAS) to be cost-effective, it should be delivered in centres performing ≥150 cases/year [4] . The median number of cases of RP per surgeon and per centre has increased in recent years, reflecting a trend towards this centralisation; however, there remain significant differences in case volumes between surgeons and centres.
The present analysis provides an overview of the data on RP practice for the combined period of 2014 and 2015, in addition to highlighting differences in reported practice and outcomes for surgeons and centres with differing case volumes.
Patients and Methods
Data were uploaded prospectively by individual surgeons or units (both NHS and private) across the UK to the BAUS electronic data registry. Surgeons were given two opportunities to validate their data and ensure accuracy. Data were then extracted from the registry and transferred to an Access TM database, where they were validated and analysed using Tableau TM software. Centre case-volumes were pragmatically grouped in to 'high' (>200), 'medium' (100-200) and 'low' (<100); surgeon casevolumes in to 'high' (>100) and 'low' (<100). Differences in surgical practice and outcome were observed between groups. All data presented in the present paper are for the combined 2-year period.
Results
Volume of Cases Performed The total numbers of cases performed, delineated by surgical approach, are shown in Table 1 .
Surgical Approach
Overall, the most common surgical approach was RALP (65%), followed by laparoscopic RP (LRP; 23%) and open RP (ORP; 12%) ( Table 1) . High-volume centres performed RALP in 74.3% of their cases compared to 36.8% in lowvolume centres. This difference was less marked when comparing high-and low-volume surgeons. In considering NICE guidance, 43% of patients in the present cohort met the criteria of having had their RP performed robotically by a surgeon whose case volume was >50 RPs/ year. About half (51.6%) of all the procedures over the 2-year period were performed as a RALP in high-volume centres.
NS Procedures
Overall, 53.6% of patients underwent a NS procedure, of which just over half were bilateral (30.4% overall). Figure 3 shows the reported NS rates by centre and surgeon case-volume. There is no adjustment for case-mix, which may in itself be a major determinant of whether NS is offered.
Lymph Node Dissection
Overall, 36.3% of patients underwent a LND and this area of practice was reasonably consistent across all groups ( Table 2 ). The reported rates of 'extended' LND (eLND; defined as to the common iliac bifurcation) were seen to differ and were highest in high-volume centres. Again, there is no adjustment for case-mix in the present series. LND was not recorded in 7.8% of registry data.
Length Of Stay
Length of stay in the UK is defined as the total number of nights spent in a hospital bed. The median LOS varied by surgical approach (Table 3) , with ORP consistently having the longest LOS. Where minimal access surgery was performed, median LOS improved to 1-2 days. Centres and surgeons using RAS within a high-volume practice reported the shortest median LOS of 1 day. LOS was not recorded in 0.6% of registry data.
Surgical Margins
Positive surgical margin rates for organ-confined (pT2) cases were observed; pT2 disease represented 47.3% of cases in the data set. Figure 4 shows the reported rates of PSM in pT2 cases by surgeon and centre case-volume. The data are further divided according to surgical approach. Overall, RALP was associated with a lower PSM rate for patients with pT2 pathology (16.0%) when compared with LRP (21.2%) and ORP (23.5%). The reported rate of PSM was lowest for highvolume centres (14.0%) and surgeons (13.6%) when using a robot-assisted approach. In all, 0.5% of data were not recorded in this category of organ-confined PSM rates.
Transfusion Rates
Transfusion rates were available for 91% of the data set.
Reported transfusion rates are summarised in Table 4 . Overall, the reported transfusion rates were lower when minimally invasive surgery was used. Highest rates of transfusion were reported in the ORP group across all sub-categories. In all, 0.6% of transfusion rate data were listed as not recorded.
Training Cases
The grade of operating surgeon was available for 47.3% of registry data. In general, only a minority of reported cases were designated as training cases. The highest number of reported training cases (main operating surgeon recorded as surgical registrar) was in the RALP group in high-volume centres (7.6%) and surgeons (6.3%). Overall, high-volume centres reported 5.97% training cases in comparison to medium-(1%) and low-volume centres (0.5%). Only 0.6% of ORP and 1.5% of LRP were recorded as training cases.
Discussion
Compliance with upload of data to the BAUS data and audit project is high and the data collected represents 95% of total RPs performed over this period when compared to HES data. In contrast to individual case series, the present data offers a comprehensive population-based view of the delivery of RP across a wider health service. Furthermore, it can be used longitudinally to assess progress at a national level with compliance to treatment guidelines and recommendations.
Most cases were performed in high-volume centres and by high-volume surgeons, which reflects the trend towards centralisation of complex surgical services. NICE recommend centres perform ≥150 RALPs/year for RAS to be cost effective [4] . However, this recommendation is specific to RPs and does not take in to account the cost-effectiveness when factoring in other uses for RAS within a centre. We found that 13 of the 86 centres performed >300 RALPs over the 2-year period. These were high-volume centres accounting for most RALP cases nationally. Overall, 64.6% of men who had a RP had this performed with RAS and 62.8% of these were performed by high-volume surgeons.
In their recommendations, NICE considered the outcomes of transfusion rate, LOS, PSM and adverse events to be the most important, as they show clinically important differences between RALP, LRP and ORP [4] .
Although we used registry data and cannot assume cause and effect, we found similar differences in outcomes between the different surgical approaches.
Transfusion rates were low in general; however, ORP showed consistently higher rates than RALP or LRP across centres and surgeons. The difference in rates between RALP and LRP were variable, with a trend towards higher rates for LRP, except in high-volume centres. These findings are consistent with previous systematic reviews and meta-analyses [6, 7] , which showed lower transfusion rates in minimally invasive RALP  1  2  2  1  2  LRP  2  2  2  2  2  ORP  4  3  3 A shorter LOS (1 day) favoured RALP delivered in highvolume centres by high-volume surgeons. LOS after RALP and LRP was consistently shorter than ORP across all groups. A shorter LOS is viewed more favourably in the UK healthcare system and therefore caution must be taken when comparing to literature from other healthcare systems. Even so, these findings are reflected in the literature, which show that ORP has a longer LOS than minimally invasive surgery, but between RALP and LRP the difference is variable [6] [7] [8] .
In their meta-analysis, Tewari et al. [6] found a significantly shorter LOS for RALP compared to LRP in both USA and non-USA studies.
Reported pT2 PSM rates varied across centres and by surgical approach in keeping with other published findings that showed inconsistent and non-significant differences [6] [7] [8] .
The main difference observed in our present data was between high-and low-volume surgeons (13.6% vs 17.7%). There is little in the literature comparing these groups, the main evidence stemming from surgeon learning curves for RALP to minimise PSM rates [9] .
Ramsay et al. [10] show in their Health Technology Assessment (which is used for NICE guidelines) that PSM rates are significantly lower in RALP when compared to LRP. We found lower rates in RALP compared to LRP across centres and surgeons, although the differences varied somewhat, which could be accounted for by surgeon variation and/or case selection.
More than half the patients in the present series were recorded as undergoing NS surgery, the majority being bilateral. This was more likely in high-volume centres and by high-volume surgeons, although case mix and surgical technique was not accounted for when comparing these groups. It is important to note that the clinical implication of NS surgery on adverse events, such as erectile dysfunction, cannot be inferred from these data.
European Association of Urology (EAU) guidelines suggest an eLND for patients with intermediate-and high-risk locally advanced prostate cancer; limited LND should no longer be performed -a recent change in guidelines, which may impact data for the coming years [11] . We found the highest rates of eLND were in high-volume centres by high-volume surgeons, potentially due to increased surgical experience and faster operative time in those groups.
We found that RAS is associated with high-volume practice, which in turn is associated with higher reported rates of NS surgery and eLND. Although we cannot infer that RAS makes eLND or NS surgery easier or more likely to be performed, there may be an associated factor of the robotic platform allowing surgical manoeuvres to be more easily performed. Alternatively, the volume of surgical practice could be a major confounder in this setting and may erroneously overestimate the impact of RAS.
In conclusion, this 2-year series from well-complied national registry data shows contemporary practice in RP, with 
Limitations
The data are self-reported, which raises the potential for inaccurate reporting and, as stated, there are fields with degrees of incomplete data entry. There is no adjustment for case-mix and selection bias. Interpreting any differences or inferring causation should be undertaken cautiously due to the high likelihood of confounding factors and incomplete data. The resources needed to upload data are not directly reimbursed and its subsequent collation and analysis is currently funded predominantly by BAUS. The sustainability of this approach is under review. 
